New test could help doctors predict pancreatic cancer treatment success

NCT ID NCT07542041

First seen Apr 30, 2026 · Last updated May 22, 2026 · Updated 11 times

Summary

This study is testing a new test called NEO-Match® that uses nanomechanical profiling to see if it can predict how well pancreatic cancer patients respond to treatment. About 200 adults with suspected pancreatic cancer will provide an extra biopsy sample during their standard care. The test results will be compared to standard outcomes to see if it can improve diagnosis and treatment decisions. No experimental treatments are given, and participants continue their usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.